The ProVIDE study is a prospective, randomized, double-blind, sham controlled study evaluating the safety and effectiveness of the ProVee® Urethral Expander System for the treatment of lower urinary ...

LAS VEGAS -- A novel, non-ablative intervention for lower urinary tract symptoms (LUTS) produced rapid, durable symptom ...

Medical device company Zenflow has reported that its Spring System demonstrated durable benefits three years post-placement ...

Term Data among FIT InterventionsSOUTH SAN FRANCISCO, Calif., April 26, 2025 (GLOBE NEWSWIRE) -- Zenflow, Inc. announced today the results of long-term data demonstrating that the investigational ...

PROCEPT BioRobotics Corporation’s PRCT share price has dipped by 5.04%, which has investors questioning if this is right time ...

And Parekh and Morton? Well, they both punctuated their first NHL games by scoring their first NHL goals. “I think that’s good as it gets,” a beaming Parekh told reporters post-game before ...

NHL scoring at its highest levels in Gretzky era Some will argue that Ovechkin is a greater goal scorer because scoring has become more challenging. Gretzky's early years were played when the NHL ...

For years, middle-aged men have stocked their medicine cabinets with a certain berry-based remedy touted as nature’s answer to bathroom woes. Now, Harvard doctors are saying this popular pill is ...

New York Yankees pitcher Max Fried had a no-hitter going late into Sunday’s game against the Tampa Bay Rays, and he lost it after a controversial scoring change. Fried did not allow a hit ...

Non-responders may have BPH attributable to mechanical obstruction ... urinary flow rate and improving patients' voiding symptom score and that both formulations were more effective than placebo.

Since joining the Yankees in free agency during the offseason, Max Fried as been sensational in his first five starts. And Sunday's game against the Rays was his best Yankees outing to date with ...